Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:Corticosteroid |
| gptkbp:approvedBy |
1998
|
| gptkbp:ATCCode |
S01BA14
|
| gptkbp:CASNumber |
82034-46-6
|
| gptkbp:chemicalFormula |
C24H31ClO7
|
| gptkbp:contraindication |
fungal eye infections
viral eye infections tuberculosis of the eye |
| gptkbp:developedBy |
gptkb:Bausch_&_Lomb
|
| gptkbp:eliminationHalfLife |
short
|
| gptkbp:form |
ophthalmic ointment
ophthalmic suspension ophthalmic gel |
| https://www.w3.org/2000/01/rdf-schema#label |
loteprednol etabonate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
glucocorticoid receptor agonist
|
| gptkbp:metabolism |
rapidly metabolized to inactive metabolites
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
blurred vision
increased intraocular pressure eye irritation |
| gptkbp:synonym |
gptkb:Alrex
gptkb:Lotemax |
| gptkbp:usedFor |
allergic conjunctivitis
inflammatory eye conditions post-operative eye inflammation |
| gptkbp:bfsParent |
gptkb:Alrex
gptkb:Lotemax gptkb:Lotemax_Gel |
| gptkbp:bfsLayer |
7
|